*Key Highlights of a Pharmaceutical manufacturing company for sale near Nagpur, Maharashtra*
# WHO-GMP certified company.
# They have many approvals, like, the neutral code certificate for export, the state GMP certificate, and product approvals.
# All required government approvals related to industrial land, pollution departments, etc. are approved.
# Their three trademarks are registered.
# With an effort of more than a year, they have formulated their own oral suspension, Cefuroxime Axetil 250mg USP. This product is produced by very few manufacturers.
# Despite of pandemic situation, they started working with 5 new customers, completed initial orders, and, with the trust of clients, received re orders.
# Yemen, Sri Lanka, Cambodia, Abu Dhabi, and Egypt, new customers are in the process of registering.
# Within a short span, despite the Corona restriction, we achieved breakeven.
# Production line is established with minimum waste and reprocessing
# All investment in machinery is appreciated by a minimum of 35%.
# The value of land has appreciated by 200% in the last three years.
# District Industries Cooperation of Maharashtra has sanctioned INR 6,87,00,000 to be given in the next 10 years. They will get the first part of the subsidy in a couple of months after documents are filed.
# All required Government approvals related to Industrial Land, Pollution Dept. etc. are approved.
# Despite maintaining all industrial standards, the company is working on the minimum cost of production and management. Partners are personally involved in all activities to achieve growth and targets.
# Ample space is available for expansion in the same facility for capsules, cachets, and injectables with a minimum investment.
# Plant capacity:
6 lakh Tablets per shift
13000 bottles per shift
# Total construction is 36,000 Sq. ft. ground plus the first floor
# Tablets and Dry Syrup sections are in place. Capsule section just got the approval.
# Plant is dedicated for Cephalosporins Formulations manufacturing only.
# To achieve maximum growth with minimum expenses, partners are not taking any remuneration.
# Complete transparency of business.
# Projection Turnover: Oct 21– March 22
Projection is around 9 Crore
# Projections for next 5 years:
Tentative projections :
FY 2023 – 15 Crores
FY 2024 – 22 Crores
FY 2025 – 30 Crores
FY 2026 – 40 Crores
FY 2027 - 50 Crores
*Asking Price : ₹ 15 Cr.*
